Karina Galoian

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells

Luyuan Li, Ana C. Paz, Breelyn A. Wilky et al. · PLoS ONE · 2015 · 106 citations · Full text

Medicine, Cancer Biology, Oncology +12

Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma

Karina Galoian, Toumy Guettouche, Biju Issac et al. · Tumor Biology · 2013 · 30 citations

Medicine, Cancer Biology, Oncology +17

mTORC1 inhibition and ECM–cell adhesion-independent drug resistance via PI3K–AKT and PI3K–RAS–MAPK feedback loops

Karina Galoian, H. Thomas Temple, Armen A. Galoyan · Tumor Biology · 2012 · 29 citations

Medicine, Oncology, Pharmacology +15

Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth

Luyuan Li, Xiaoyu Hu, Josiane E. Eid et al. · Cancers · 2020 · 26 citations · Full text

Medicine, Molecular Biology, Oncology +16

Cytostatic Effect of the Hypothalamic Cytokine PRP-1 is Mediated by mTOR and cMyc Inhibition in High Grade Chondrosarcoma

Karina Galoian, Thomas H. Temple, Armen A. Galoyan · Neurochemical Research · 2011 · 22 citations

Life Sciences, Neuroscience, Pharmacology +16